Frontier Capital Management’s Boston Scientific BSX Stock Holding History

Frontier Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-807	Closed	-$22K	–	304
2018 Q1	$22K	Hold	807	–	–	﹤0.01%	303
2017 Q4	$20K	Hold	807	–	–	﹤0.01%	312
2017 Q3	$24K	Hold	807	–	–	﹤0.01%	307
2017 Q2	$22K	Hold	807	–	–	﹤0.01%	311
2017 Q1	$20K	Hold	807	–	–	﹤0.01%	314
2016 Q4	$17K	Sell	807 -102	-11%	-$2.23K	﹤0.01%	315
2016 Q3	$22K	Sell	909 -186	-17%	-$4.44K	﹤0.01%	328
2016 Q2	$26K	Hold	1,095	–	–	﹤0.01%	315
2016 Q1	$21K	Hold	1,095	–	–	﹤0.01%	322
2015 Q4	$20K	Buy	1,095 +120	+12%	+$2.15K	﹤0.01%	335
2015 Q3	$16K	Hold	975	–	–	﹤0.01%	341
2015 Q2	$17K	Buy	975 +216	+28%	+$3.86K	﹤0.01%	353
2015 Q1	$13K	Buy	+759	New	+$12K	﹤0.01%	360

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Frontier Capital Management's BSX Position: Q2 2018 in Review

Frontier Capital Management sold out of Boston Scientific (BSX) in Q2 2018, closing a stake of 807 shares — an estimated $22K sold.

Frontier Capital Management first reported a position in BSX in Q1 2015 and held it in 13 quarters. The position peaked at $26K in Q2 2016. 671 funds tracked by Wall St. Rank hold BSX as of Q2 2018.

Frontier Capital Management reported no remaining Boston Scientific position as of Q2 2018 after selling out during the quarter.
Frontier Capital Management sold 807 Boston Scientific shares in Q2 2018, an estimated $22K.
Frontier Capital Management first reported a position in Boston Scientific in Q1 2015 and held it in 13 quarters.
Frontier Capital Management's Boston Scientific position peaked at $26K in Q2 2016.
671 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2018.

Based on Frontier Capital Management's 13F filing for Q2 2018, filed 3 Aug 2018.